# Effects of Intraarticular Botulinum Toxin A in Ankle Osteoarthritis

> **NCT01760577** · NA · COMPLETED · sponsor: **Kaohsiung Veterans General Hospital.** · enrollment: 70 (actual)

## Conditions studied

- Ankle Osteoarthritis

## Interventions

- **DRUG:** Botulinum Toxin A (Allergan, Inc, Irvine CA)
- **DRUG:** Hyalgan (Hyalgan, Fidia , Italy)

## Key facts

- **NCT ID:** NCT01760577
- **Lead sponsor:** Kaohsiung Veterans General Hospital.
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2012-05
- **Final completion:** 2012-11
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2013-01-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01760577

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01760577, "Effects of Intraarticular Botulinum Toxin A in Ankle Osteoarthritis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01760577. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*